LAROTID Drug Patent Profile
✉ Email this page to a colleague
When do Larotid patents expire, and when can generic versions of Larotid launch?
Larotid is a drug marketed by Glaxosmithkline and Us Antibiotics and is included in two NDAs.
The generic ingredient in LAROTID is amoxicillin. There is one drug master file entry for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Larotid
A generic version of LAROTID was approved as amoxicillin by TEVA on December 22nd, 1992.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for LAROTID?
- What are the global sales for LAROTID?
- What is Average Wholesale Price for LAROTID?
Summary for LAROTID
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 61 |
| Patent Applications: | 2,004 |
| DailyMed Link: | LAROTID at DailyMed |
US Patents and Regulatory Information for LAROTID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | LAROTID | amoxicillin | FOR SUSPENSION;ORAL | 050460-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Us Antibiotics | LAROTID | amoxicillin | FOR SUSPENSION;ORAL | 062226-003 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Us Antibiotics | LAROTID | amoxicillin | FOR SUSPENSION;ORAL | 062226-004 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
